Videos

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.

In Belgium, every year more than 25,000 people return to work after cancer treatment. Yet there are many employers who do not know how to react in such a situation. Elise Pattyn (Arteveldehogeschool) and her colleagues are working on tools to make the return to work smoother.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.

Cracking codes, it's a thing in escape rooms. But it is also what Bénedith Oben tries, albeit in the laboratory. In this way, she hopes to find the key to better understand the development of multiple myeloma, a common blood cancer.

It is a relatively new and promising path in cancer research: the reuse of old, non-cancer drugs. In her PhD, Laurie Freire Boullosa focuses on an old rheumatism pill and examines whether it can be used as a weapon against cancer.

Imagine having to visit the toilet 30 times a day for 'number two'. That's not possible, right? Unfortunately, it's the reality for a lot of patients with rectal cancer who've had rectal surgery. Anne Asnong tries to help these people so that they no longer have to spend their life 'chained' to the toilet seat. 🚽

With the current corona pandemic, viruses are seen as more dangerous than ever. But did you know that some viruses can help us fight cancer? Jolien De Munck is studying the potential of these so-called 'oncolytic viruses'.

Quitting smoking is quite a challenge. In her PhD, Karolien Adriaens (KU Leuven) shows that the e-cigarette is an effective tool to help smokers eventually get rid of their addiction.